Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Olive

Showing results (261-270 of 305) with videos related to

Pageof 31
Sort By:
European Journal of Immunology|January 1, 1984
Absence of cell surface fixation of a monoclonal antibody detectable by conventional immunoassays does not exclude expression of and interaction with the corresponding antigenic determinantC Layet, P P Le Bouteiller, D Olive, et al.
Leukemia & Lymphoma|August 26, 1998
Anti-GM-CSF monoclonal antibody therapy for refractory acute leukemiaR Bouabdallah, D Olive, P Meyer, et al.
Blood|September 15, 1990
Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantationD Blaise, D Olive, A M Stoppa, et al.
Lancet (London, England)|November 8, 1986
Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantationA Fischer, C Griscelli, S Blanche, et al.
Haematology and Blood Transfusion|January 1, 1987
Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenanceG Schaison, G Leverger, A Bancillon, et al.
Leukemia|October 26, 2002
Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemiaM Mohty, D Isnardon, D Blaise, et al.
Bone Marrow Transplantation|January 1, 1991
Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT)D Blaise, D Guyotat, J Reiffers, et al.
Blood|November 1, 1991
High-dose recombinant interleukin-2 and acute myeloid leukemias in relapseD Maraninchi, D Blaise, P Viens, et al.
Bone Marrow Transplantation|January 1, 1991
Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 studyD Blaise, A M Stoppa, D Olive, et al.
AIDS (London, England)|December 1, 1989
Pilot phase I study using zidovudine in association with a 10-day course of anti-CD4 monoclonal antibody in seven AIDS patientsC Dhiver, D Olive, S Rousseau, et al.
Pageof 31

Showing results (261-270 of 305) with videos related to

Sort By:
Pageof 31
European Journal of Immunology|January 1, 1984
Absence of cell surface fixation of a monoclonal antibody detectable by conventional immunoassays does not exclude expression of and interaction with the corresponding antigenic determinantC Layet, P P Le Bouteiller, D Olive, et al.
Leukemia & Lymphoma|August 26, 1998
Anti-GM-CSF monoclonal antibody therapy for refractory acute leukemiaR Bouabdallah, D Olive, P Meyer, et al.
Blood|September 15, 1990
Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantationD Blaise, D Olive, A M Stoppa, et al.
Lancet (London, England)|November 8, 1986
Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantationA Fischer, C Griscelli, S Blanche, et al.
Haematology and Blood Transfusion|January 1, 1987
Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenanceG Schaison, G Leverger, A Bancillon, et al.
Leukemia|October 26, 2002
Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemiaM Mohty, D Isnardon, D Blaise, et al.
Bone Marrow Transplantation|January 1, 1991
Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT)D Blaise, D Guyotat, J Reiffers, et al.
Blood|November 1, 1991
High-dose recombinant interleukin-2 and acute myeloid leukemias in relapseD Maraninchi, D Blaise, P Viens, et al.
Bone Marrow Transplantation|January 1, 1991
Use of recombinant IL-2 (RU49637) after autologous bone marrow transplantation (BMT) in patients with hematological neoplasias: a phase 1 studyD Blaise, A M Stoppa, D Olive, et al.
AIDS (London, England)|December 1, 1989
Pilot phase I study using zidovudine in association with a 10-day course of anti-CD4 monoclonal antibody in seven AIDS patientsC Dhiver, D Olive, S Rousseau, et al.
Pageof 31